维普中文期刊产品整合服务
156篇 您的检索式:作者名="Crystal E"
    题名 作者 年代 出处 被引量
1Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas显示文摘Pancreatic cancer is one of the deadliest cancers with a very poor prognosis. Recently, there has been a significant increase in research directed towards identifying potential biomarkers that can be used to diagnose and provide prognostic information for pancreatic cancer. These markers can be used clinically to optimize and personalize therapy for individual patients. In this review, we focused on 3 biomarkers involved in the DNA damage response pathway and the necroptosis pathway: Chromodomainhelicase-DNA binding protein 5, chromodomain-helicaseDNA binding protein 7, and mixed lineage kinase domain-like protein. The aim of this article is to review present literature provided for these biomarkers and current studies in which their effectiveness as prognostic biomarkers are analyzed in order to determine their future use as biomarkers in clinical medicine. Based on the data presented, these biomarkers warrant further investigation,and should be validated in future studies.Crystal S Seldon Lauren E Colbert William A Hall Sarah B Fisher David S Yu Jerome C Landry 2016World Journal of Gastrointestinal Oncology2016,8,4:2
2Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coil Cardiol2005,45,11:1
3Prevent ion of atrial fibrilla- tion with angiotensin- converting enzyme inhibitors and angiotens in re- cept or blocders: a meta-analysis 显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coil Cardiol2005,45,11:1
4Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers : a meta-analysis 显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coll Cardiol2005,45,:1
5Left Atrial Appendage Occlusion Study(LAAOS) :results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke显示文摘Healey JS Crystal E Lamy A 2005Am Heart J2005,150,:1
6Role of oral anticoagulation in management of atrial fibrillation 显示文摘Crystal E Connolly SJ 2004Heart2004,90,7:1
7Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers:a meta-analysis显示文摘Healey JS Baranchuck A Crystal E 2005J Am Coll Cardiol2005,45,11:1
8Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers : a meta-analysis 显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coll C ardiol2005,45,11:1
9Interventions for preventingpost-operative atrial fibrillation in patients undergoing heartsurgery显示文摘Crystal E Garfinkle MS Connolly SS 2004Cochrane Database Syst Rev2004,18,4:1
10Sex dif erences in implantable cardioverter-defibril ator outcomes:findings from a prospective defibrillator database显示文摘MacFadden D R Crystal E Krahn A D 0,,03:1
11Prevention of atrial fibrillation with angiotensin - converting enzyme inhibitors and angiotensin receptor blockers : a meta - analysis显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coll Cardiol2005,45,:1
12Prevention of atrial fibrillation with angiotensin - converting enzyme inhibitors and angiotensin receptor blockers: a meta - analysis显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coil Cardiol2005,45,:1
13Left atrial appendage exclusion for stroke pre- vention in patients with nonrheumatic atrial fibrillation显示文摘Onalan O Crystal E 2007Stroke2007,38,2:1
14Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype显示文摘Gall J G Crystal R G Falck-Pedersen E 1998J Virol1998,72,10:1
15Left atrial ap- pendage qcclusion study : results of a randomized controlledpilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke显示文摘HEALEY J S CRYSTAL E LAMY A 2005Am Heart J2005,150,2:1
16Prevention of atrial fi- brillation with angiotensin-converting enzyme inhibitors and an- giotensin receptor blockers: a meta-analysis 显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coll Cardiol2005,45,11:1
17Prevention of atrial fibrillation with congiotensinconverting enzyme inhibitors and angiotensin receptor blockers显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coll Cardiol2005,45,12:1
18Prevention of atrial fibrillation withangiotensin-converting enzyme inhibitors and angiotensin receptor blockers:ameta-analysis显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coil Cardiol2005,45,2:1
19Prevention of atrial fibril- lation with angiotensin-converting enzyme inhibitors and angioten- sin receptor blockers : a meta-analysis 显示文摘Healey JS Baranchuk A Crystal E 2005J Am Coil Cardiol2005,45,:1
20Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angio- tensin receptor blockers: A Meta-Analysis显示文摘Healey J S Baranchuk A Crystal E 2005J Am Coll Cardiol2005,45,11:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费